Skip to main content
Top
Published in: Bulletin of Experimental Biology and Medicine 1/2009

01-07-2009 | Cell Technologies in Biology and Medicine (Translated from Kletochnye Tekhnologii v Biologii i Meditsine)

Effect of Transplantation of Peripheral Blood Mononuclears Obtained Using Granulocytic Colony-Stimulating Factor and Hyaluronidase on Regeneration of Hemopoietic Tissue during Myelosuppression

Authors: A. M. Dygai, G. N. Zyuz’kov, V. V. Zhdanov, E. V. Simanina, L. A. Stavrova, E. V. Udut, T. Yu. Khrichkova, M. Yu. Minakova, N. N. Ermakova, T. V. Firsova

Published in: Bulletin of Experimental Biology and Medicine | Issue 1/2009

Login to get access
Metadata
Title
Effect of Transplantation of Peripheral Blood Mononuclears Obtained Using Granulocytic Colony-Stimulating Factor and Hyaluronidase on Regeneration of Hemopoietic Tissue during Myelosuppression
Authors
A. M. Dygai
G. N. Zyuz’kov
V. V. Zhdanov
E. V. Simanina
L. A. Stavrova
E. V. Udut
T. Yu. Khrichkova
M. Yu. Minakova
N. N. Ermakova
T. V. Firsova
Publication date
01-07-2009
Publisher
Springer US
Published in
Bulletin of Experimental Biology and Medicine / Issue 1/2009
Print ISSN: 0007-4888
Electronic ISSN: 1573-8221
DOI
https://doi.org/10.1007/s10517-009-0655-3

Other articles of this Issue 1/2009

Bulletin of Experimental Biology and Medicine 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine